PROVETOP

Human CD161 Protein

Catalog No: CD161-HF001

Species
Human
Expression System
HEK293
Tag
an hFc (IgG1)
Activity
Activity verified

Product overview

Recombinant Human CD161 Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus. It contains amino acid residues Gln67-Ser225 (UniProt accession: Q12918-1).

Product Details

Molecular Aliases
KLRB1; CLEC5B; NKRP1A; NKR-P1A; HNKR-P1a; CD161; Ly59; NKR; NKRP1; NKR-P1; NKRP1ANKR
Protein Length
Gln67-Ser225
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 45.2 kDa. Due to glycosylation, the protein migrates to 65-68 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
CD161-HF001 Bis-Tris-PAGE-white result

Human CD161 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
CD161-HF001 SEC-HPLC result

The purity of Human CD161 is greater than 90% as determined by SEC-HPLC.

ELISA
CD161-HF001 ELISA result

Immobilized Human CD161, hFc Tag at 2μg/ml (100μl/Well) on the plate. Dose response curve for Biotinylated Anti-CD161 Antibody, hFc Tag with the EC50 of 39.1ng/ml determined by ELISA (QC Test).

Background

CD161 (NKRP1) is a lectin-like receptor present on NK cells and rare T-cell subsets. We have observed CD161 expression in some cases of T-cell prolymphocytic leukemia (T-PLL) and found it to be useful in follow-up and detection of disease after treatment.

References

  1. Gilles SR, Yohe SL, Linden MA, Dolan M, Hirsch B, Grzywacz B. CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up. Am J Clin Pathol. 2019 Sep 9;152(4):471-478. doi: 10.1093/ajcp/aqz060. PMID: 31305900.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support